NPPA fixes the retail price of formulations of Vildagliptin and Metformin HCL Tablet

The National Pharmaceutical Pricing Authority (NPPA) on August 27, 2020 has passed an order to fix the retail price of formulations of ‘Vildagliptin + Metformin HCL Tablet’ under the Drugs (Prices Control) Order, 2013.

Strength	Unit	Manufacturer and Marketing company	Retail Price (Rs.)
Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Glenmark Pharmaceuticals Limited	6.17

The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price. The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price in the above table. The manufacturer shall issue a price list in Form–V from date of Notification to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer or marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.